An expanded indication is a specific result
LinkedIn caption
🫀 An expanded indication is useful evidence precisely because its scope is defined.
Wegovy's FDA cardiovascular indication covers reducing major cardiovascular events in adults with established cardiovascular disease and overweight or obesity. It is an example of an additional clinical use supported by dedicated evidence, not a general approval to treat aging.
For the dual-purpose drug discussion at ARDD 2026, this suggests a disciplined sequence: identify the first clinical need, generate the evidence, and investigate additional uses on their own terms. A broader biological story can motivate that work while the approved claim stays specific.
#ARDD2026 #DrugDiscovery #ClinicalTrials #Healthspan
X caption
🫀 Wegovy's cardiovascular indication is specific: adults with established cardiovascular disease and overweight or obesity. Additional clinical evidence supported that use; it is not an approval to treat aging. #ARDD2026 #DrugDiscovery #Healthspan
Credit: Michael DeStefano
Copy and paste the caption manually, then attach the downloaded photo. Nothing is published automatically.
